West Pharmaceutical Services | WST - Assets



West Pharmaceutical Services reported $3.95B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Align Technology USD 6.22B 116.27M Jun/2025
Avanos Medical USD 1.04B 68.8M Jun/2025
Baxter International USD 21.3B 4.48B Mar/2025
Becton, Dickinson and Co. USD 54.9B 435M Jun/2025
Charles River Laboratories USD 7.56B 21.82M Jun/2025
Cooper Companies USD 12.38B 36.9M Jul/2025
Dentsply International USD 6.07B 19M Jun/2025
Haemonetics USD 2.46B 11.15M Jun/2025
ICU Medical USD 4.11B 77.19M Jun/2025
Insulet USD 3.47B 48.1M Jun/2025
Integra LifeSciences USD 3.67B 384.85M Jun/2025
IQVIA Holdings USD 28.63B 1.31B Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Medtronic USD 91.68B 1.71B Apr/2025
Merit Medical Systems USD 2.59B 118.07M Jun/2025
Neogen USD 3.44B 592.5M May/2025
Quidel USD 6.38B 82.5M Jun/2025
Repligen USD 2.85B 22.48M Mar/2025
Solventum Corp 15.07B 547M Jun/2025
STAAR Surgical USD 437.78M 19.58M Jun/2025
Terumo JPY 1.8T 28.96B Jun/2025
West Pharmaceutical Services USD 3.95B 334.6M Jun/2025